These effects were mediated by the suppression of tumor-associated proteins and the modulation of different signaling pathways such as the regulation of NF-κB, Wnt/β-catenin, cyclin D1, p21/WAF1/CIP1, p27/KIP1, and cyclin-dependent kinases [149]. This evidence concerns the gene CDKN1A and neoplasm.